Skip to main content
. 2020 Oct 21;18(4):2133. doi: 10.18549/PharmPract.2020.4.2133

Table 1. Baseline patient characteristics.

Characteristic valid (n=1403) Summary Statistic p-value

Control Group (n=715) Intervention Group (n=688)
Age; mean (SD) 1403 74.92 (6.59) 75.34 (6.46) 0.243
Gender: Female; n (%) 1396 441 (61.7) 409 (60.1) 0.535
Partner Status:with partner; n (%) 1242 384 (59.3) 355 (59.8) 0.856
Education; n (%) 1174 0.004
No formal education 116 (18.7) 149 (27)
Completed primary education 313 (50.3) 239 (43.3)
Completed secondary education 135 (21.7) 106 (19.2)
Completed university education 58 (9.3) 58 (10.5)
Number of medicines; mean (SD) 1403 7.39 (2.37) 7.74 (2.50) 0.009
Number of health problems 1403 4.35 (1.49) 4.96 (1.76) <0.001
Number of uncontrolled health problems;median (IQR) 1403 0.73 (0.66-0.8) 1.46 (1.36-1.56) <0.001